Brief: China Resources Pharmaceutical Says FY Net Profit Attributable For Jiangzhong Pharmaceutical Was RMB788.2 Million
19/03/2025 13:01
March 19 (Reuters) - China Resources Pharmaceutical Group Ltd 3320.HK: FY NET PROFIT ATTRIBUTABLE FOR JIANGZHONG PHARMACEUTICAL RMB788.2 MILLION FY REVENUE FOR JIANGZHONG PHARMACEUTICAL RMB4.44 BILLION CASH DIVIDEND OF RMB7.00 FOR EVERY 10 SHARES OF JIANGZHONG PHARMACEUTICAL Further company coverage: 3320.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Resources Pharmaceutical
See all newsBrief: China Resources Pharmaceutical Says KPC Pharmaceuticals Reports Nine Month Results
Brief: China Resources Pharmaceutical Group Declares Interim Dividend Of RMB0.087 Per Share
Brief: China Resources Pharmaceutical Says Tasly Pharmaceutical Posts HY Net Profit Attributable Of RMB 892.7 MLN
Brief: China Resources Pharmaceutical Group Says HY Revenue RMB 1.93 Billion For CR Jiangzhong
Brief: China Resources Pharmaceutical Group Posts HY Revenue RMB 1.64 Billion, Down 50.97% For KPC Pharmaceuticals